Healthcare Value Capital as of June 30, 2021
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 22 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 10.3 | $5.2M | 75k | 68.87 | |
| Glaxosmithkline Sponsored Adr | 7.9 | $4.0M | 100k | 39.82 | |
| Pfizer (PFE) | 7.8 | $3.9M | 100k | 39.16 | |
| Alkermes SHS (ALKS) | 7.3 | $3.7M | 150k | 24.52 | |
| Bristol Myers Squibb (BMY) | 6.7 | $3.3M | 50k | 66.82 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 6.4 | $3.2M | 250k | 12.87 | |
| Merck & Co (MRK) | 6.2 | $3.1M | 40k | 77.78 | |
| Astrazeneca Sponsored Adr (AZN) | 6.0 | $3.0M | 50k | 59.90 | |
| Clovis Oncology | 5.8 | $2.9M | 500k | 5.80 | |
| Amryt Pharma Sponsored Ads | 4.8 | $2.4M | 200k | 12.13 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 4.7 | $2.4M | 100k | 23.64 | |
| Antares Pharma | 4.3 | $2.2M | 500k | 4.36 | |
| Tyme Technologies | 3.8 | $1.9M | 1.5M | 1.26 | |
| Vyne Therapeutics | 3.1 | $1.6M | 450k | 3.51 | |
| Greenlane Hldgs Cl A | 3.1 | $1.6M | 350k | 4.47 | |
| MiMedx (MDXG) | 3.1 | $1.6M | 125k | 12.51 | |
| Proshares Tr Ultrapro Sht Qqq Call Option | 1.8 | $914k | 100k | 9.14 | |
| Proshares Tr Ultrapro Short S Call Option | 1.8 | $911k | 50k | 18.22 | |
| Amarin Corp Spons Adr New Call Option (AMRN) | 1.7 | $876k | 200k | 4.38 | |
| Proshares Tr Ii Vix Sh Trm Futrs Call Option | 1.2 | $602k | 25k | 24.08 | |
| Adamas Pharmaceuticals | 1.1 | $528k | 100k | 5.28 | |
| Gamida Cell SHS | 1.0 | $481k | 75k | 6.41 |
